Articles Mentioning Life Sciences Tools and Services Stocks

Results 1 - 10 of 413 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Life Sciences Tools and Services

Investing | April 25, 2016

Is Pacific Biosciences or Illumina Corp. a Better Buy?

Illumina shares are dropping, and Pacific Biosciences' are climbing, but investors may not want to count Illumina out.

Investing | April 20, 2016

Illumina's Gene Sequencers Are About to Revolutionize Healthcare

Illumina Corp's gene sequencing machines are reshaping how doctors will treat patients in the decades to come.

Investing | April 19, 2016

Are Illumina's Shares Worth Buying on This Drop?

Lackluster sales growth is causing shares to drop, but long-minded investors may want to consider buying.

Investing | April 19, 2016

Why Illumina Shares Are Tanking 18% Pre-Market

Lower-than-hoped first quarter performance is weighing down shares.

Investing | April 16, 2016

Healthcare's Future: Science Fiction or Science Fact

We look at genomic sequencing and robotic surgery, two of the most exciting innovations that are available in the real world today. Listen in to hear what these technologies are already able to do today, how they could take off into the future, and how interested investors should approach the companies behind them.

Investing | April 12, 2016

How Risky Is Myriad Genetics Stock?

Reimbursement and competitive challenges add risk for this molecular diagnostics leader.

Investing | March 21, 2016

Why Affymetrix, Inc. Shares Are Tumbling 10% Today

Shares are slipping after the Board of Directors rejects a higher, unsolicited acquisition offer.

Investing | March 18, 2016

Why Affymetrix, Western Digital, and Goldman Sachs Jumped Today

The markets finished the week on a strong note thanks to stocks like these. Find out why.

Investing | March 18, 2016

Is This the Biggest Threat Yet to Illumina?

The launch of a new gene-sequencing machine made by Pacific Biosciences is underway.

Investing | March 14, 2016

Is It Time to Buy Illumina Inc. Stock?

It's been a tough year so far for the genomic sequencing leader's stock. Are better days ahead?

Results 1 - 10 of 413 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Life Sciences Tools and Services